Skip to main content
Disc Medicine, Inc. logo

Disc Medicine, Inc. — Investor Relations & Filings

Ticker · IRON ISIN · US36870G1058 US Manufacturing
Open in API
Filings indexed 690 across all filing types
Latest filing 2025-01-21 Capital/Financing Update
Country US United States of America
Listing US IRON

About Disc Medicine, Inc.

https://www.discmedicine.com/

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients with serious hematologic diseases. The company's research focuses on fundamental pathways of red blood cell biology to address a range of disorders. Its pipeline includes bitopertin, an investigational therapy for erythropoietic protoporphyria (EPP) for which a New Drug Application has been submitted for accelerated approval. Other clinical-stage programs are evaluating treatments for myelofibrosis-associated anemia and other conditions involving ineffective erythropoiesis.

Recent filings

Filing Released Lang Actions
424B5
Capital/Financing Update Classification · 95% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act, related to an offering of common stock and pre-funded warrants. It includes detailed information about the offering terms, underwriting, risk factors, use of proceeds, and legal matters. The document is a registration and offering prospectus supplement, which is a type of capital raising disclosure. It is not a financial report, earnings release, management discussion, or any other type of report. It is clearly an update on a financing activity and capital structure change. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, confirming it is not a mere announcement or regulatory filing. Confidence is high due to explicit references to securities offering and registration statement.
2025-01-21 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or disclosures by a company. The text includes a detailed description of a recent FDA Type C meeting and the company's plans for a clinical trial and NDA submission. It also includes a press release as an exhibit. There are no financial statements or comprehensive financial data presented, so it is not an Annual Report (10-K) or Interim Report (IR). The document is not a transcript, audit report, or governance information. It is primarily an event disclosure and regulatory update. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories but are regulatory announcements like Form 8-K filings.
2025-01-21 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text includes a Regulation FD Disclosure about a press release on pipeline and operational progress, and an Item 8.01 Other Events section disclosing a material weakness in internal control over financial reporting expected to be reported in the upcoming annual report (Form 10-K). There are no actual financial statements or detailed financial data presented here, only disclosures and a press release. The document is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is a regulatory filing reporting material events and disclosures. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is 4657 characters, which is sufficient for a substantive filing but it is a Form 8-K, which is a regulatory filing type.
2025-01-10 English
4
Director's Dealing
2025-01-06 English
4
Director's Dealing
2025-01-03 English
Regulatory Filings 2025
Regulatory Filings
2025-01-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.